Back to search

Article

TH301, a Circadian Clock Modulator, Emerges as a Novel Anti-oncogenic Agent for Human Pancreatic Cancer Cells: the Dispensable Roles of p53, CRY2 and BMAL1 in TH301-induced CDKN1A/p21CIP1/WAF1 Upregulation

2024-12-04

Abstract excerpt

<h4>Background: </h4> Pancreatic Ductal Adeno-Carcinoma (PDAC) is a highly aggressive cancer, with lim-ited treatment options. Disruption of the circadian clock, which regulates key cellular processes, has been implicated in PDAC initiation and progression. Hence, targeting circadian clock components may offer new therapeutic opportunities for the disease. This study investigates the cytopathic ef-fects of TH301,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e353d0f4-6d07-51da-a5e1-c99d61889d0c
DOI
10.20944/preprints202412.0409.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TH301, a Circadian Clock Modulator, Emerges as a Novel Anti-oncogenic Agent for Human Pancreatic Cancer Cells: the Dispensable Roles of p53, CRY2 and BMAL1 in TH301-induced CDKN1A/p21CIP1/WAF1 UpregulationDOI 10.20944/preprints202412.0409.v1
Select a neighboring publication to make it the new centre.